Basic Study
Copyright ©The Author(s) 2015.
World J Clin Oncol. Dec 10, 2015; 6(6): 299-311
Published online Dec 10, 2015. doi: 10.5306/wjco.v6.i6.299
Table 1 Proportion of cells in each cycle phase in the absence and presence of fluoxetine
SUM149PT ControlSUM149PT 10 μmol/L FLXLate MCF10A ControlLate MCF10A 10 μmol/L FLXT47D ControlT47D 10 μmol/L FLX
24 h
Sub G1.1 1.720.66 1.7721.861.63
(0.34)1(0.55)  (0.13)(0.2)  (0.26) (0.18)
G139.6 62.41260.26 79.89256.0359.21
 (0.74)(1.02) (1.59)(0.71)  (2.05) (0.55)
S34.64 20.18223.78 10.75221.1418.26
 (1.28)(1.11) (1.16)(0.43) (1.12) (1.45)
G2/M25.26 16.12215.8 7.86221.4421.39
 (0.79)(0.3) (0.65)(0.13) (0.98) (1.32)
48 h
Sub G1.91 6.670.41 10.2631.72.66
 (0.42)(2.47)  (0.05)(0.52) (0.32) (0.39)
G146.79 67.73365.48 79.77357.5262.35
 (1.94)(1.16) (0.93)(1.3)  (2.01) (1.31)
S29.69 14.01222.24 6.59322.3318.07
 (2.79)(0.84) (0.6)(0.72) (1.54) (1.19)
G2/M22.24 11.90212.31 3.58318.9517.32
(1.08)(2.64) (0.43)(0.13) (0.24) (0.29)